Page 23 - Turkinsurance Digital Magazine

23

With the MAPFRE GO mobile application, insurance transactions are on your mobile
24/7

MAPFRE Sigorta continues to connect its customers with est contracted
the amenities of the digital age. MAPFRE Sigorta’s online institutions and
transactions platform MAPFRE Go is offered to the insured services can be
as a mobile application. With the MAPFRE GO mobile appli- reached. In ad-
cation, customers can perform insurance transactions 24/7 dition, insured
with one click, without the need to call the call center. people can
quickly and eas-
MAPFRE Sigorta continues to provide privileged services ily report dam-
to its customers with the MAPFRE GO mobile application, age to cars and
which offers the opportunity to perform insurance transac- residences with
tions 24/7 from a mobile phone. With MAPFRE GO, which a single click.
makes it easy to make all insurance transactions with one Health policy-
click without leaving home, insured people can quickly per- holders can also
form their transactions without needing to consult a call benefit from MAPFRE Sigorta’s online medical counseling
center or agents. service via the Bi’ Doktora Sor (Ask a Doctor) application.
In addition, invoices for transactions made in non-contracted
With the MAPFRE GO application, policy guarantee de- institutions are loaded and the payment is transferred to the
tails and guarantee limits can be displayed, and the near- account quickly.

The health sector evaluates merger and acquisition opportunities

International auditing and the research results; In line with their long-term value creation
consulting company EY goals, 67% of managers increase their investments in digital
has announced the results transformation and 65% in customer relations.
of its ‘23rd Global Capital
Confidence Barometer’, The decline in profitability will be short-term
which reveals the expec- According to the study, which examined the effects of the pan-
tations and near-term demic on health and life sciences companies, 89% of man-
plans of companies oper- agers stated that profitability had decreased due to the pan-
ating in the health and life demic. On the other hand, large pharmaceutical companies
sciences sector around the that conduct research on the Covid-19 treatment and vaccine
world. The pandemic has differ positively in profitability compared to other biopharma-
led health and life scienc- ceutical companies. Medical technology (Medtech) companies
es companies to reshape are negatively affected by the postponement of non-mandato-
their product and service ry surgeries in hospitals. When asked how long the impact of
portfolios, according to the pandemic on profitability will last, 76% of the executives
research that reflects the surveyed said it would be short-term and predicted that profit-
views of senior executives ability would return in 2021 or 2022.
of medium-and large-
scale companies. As part EY Turkey Health and Life Sciences Sector Leader T. Ufuk
of their post-pandemic Eren made the following assessment regarding the research re-
growth strategies, companies focus on digital transformation, sults: “Our research indicates that the pandemic has led health
accelerating technology investments to improve their opera- and life sciences companies to reshape their portfolios in line
tional competencies and expand into new markets and evalu- with their long-term plans and changing needs. The vast ma-
ate merger and acquisition opportunities. 43% of executives jority (90%) of managers say they have thoroughly reviewed
who participated in the survey state that their companies will their business strategies and portfolios, while more than half
actively evaluate merger and acquisition opportunities in the (56%) say the pandemic has had an accelerating effect on the
next 12 months. change in business strategies. As the pandemic highlights the
importance of technology investments in the sector, we can
Telemedicine applications are becoming widespread say that there is a need for additional investment in the field.
In the research, it is emphasized that the way patients access As health and life sciences, companies continue to invest in
treatments has changed, especially during the pandemic peri- technology in 2021 and 2022, we can say that they will take
od, telemedicine applications have become widespread and the the opportunities that will occur in the field of mergers and
use of technology has increased in clinical trials. According to acquisitions on their agenda from a long-term perspective.”